Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.

Authors
DeWitt-J; Shnyra-A; Badr-M; Loveless-S; Hoban-D; Frame-S; Cunard-R; Anderson-S; Meade-BJ; Peden-Adams-M; Luebke-R; Luster-M
Source
Crit Rev Toxicol 2009 Jan; 39(1):76-94
NIOSHTIC No.
20034906
Abstract
Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are environmentally widespread and persistent chemicals with multiple toxicities reported in experimental animals and humans. These compounds can trigger biological activity by activating the alpha isotype of peroxisome proliferator-activated receptors (PPARs), ligand-activated transcription factors that regulate gene expression; however, some biological effects may occur independently of the receptor. Activation of the peroxisome proliferator-activated receptor alpha (PPAR alpha) modulates lipid and glucose homeostasis, cell proliferation and differentiation, and inflammation. Reported immunomodulation in experimental animals exposed to PFOA and PFOS has included altered inflammatory responses, production of cytokines and other proteins, reduced lymphoid organ weights, and altered antibody synthesis. Mounting experimental animal evidence suggests PPAR alpha independence of some immune effects. This evidence originates primarily from studies with PPAR alpha knockout models exposed to PFOA that demonstrate hepatic peroxisome proliferation, reduced lymphoid organ weights, and altered antibody synthesis. As human PPAR alpha expression is significantly less than that of rodents, potential PPAR alpha independence indicates that future research must explore mechanisms of action of these compounds, including PPAR alpha-dependent and -independent pathways. This multiauthored review contains brief descriptions of current and recently published work exploring immunomodulation by PFOA and PFOS, as well as a short overview of other PPAR alpha ligands of therapeutic and environmental interest.
Keywords
Exposure-assessment; Exposure-levels; Chemical-properties; Physiological-disorders; Physiological-factors; Physiological-response; Biological-effects; Biological-function; Biological-systems; Immune-reaction; Immunology; Liver-function; Liver; Genetic-factors; Author Keywords: Immunomodulation; Ligand-activated transcription factors; Perfluoroalkyl acids
Contact
Jamie C. DeWitt, East Carolina University, Greenville, NC 27858
CODEN
CRTXB2
Publication Date
20090101
Document Type
Journal Article
Fiscal Year
2009
NTIS Accession No.
NTIS Price
Issue of Publication
1
ISSN
1040-8444
NIOSH Division
HELD
Priority Area
Healthcare and Social Assistance; Services
Source Name
Critical Reviews in Toxicology
State
NC; SC; CA; WV; MO; DL
TOP